DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8v2p9l/ivd_in_vitro) has announced the addition of the "IVD (In Vitro Diagnostic) Testing World Markets" report to their offering.
In vitro diagnostic (IVD) testing is experiencing a revival fueled by a combination of technological improvements, cost pressures, reimbursement changes, rapid growth in molecular diagnostics and increasing interest in the genomics testing. Recent advances in molecular diagnostics technologies-including sequencing, PCR and microarray-are enabling greater sensitivity and precision in nucleic acid measurements, further expanding manufacturers' offerings.
This report is an overview of each major in vitro diagnostic testing segment, including:
- point of care testing (POCT)
- molecular diagnostics
- diabetes and glucose
- histology and cytology
- blood banking.
For each segment, this study examines the generally accepted clinical analytical activities in use today. Moreover, the analysis here discusses the potential benefits of the diagnostics techniques, as well as provides market size and future growth potential. Additionally, this report assesses the various business models, including CLIA-licensed specialty labs, general reference labs and reagent kit marketing.
Key Topics Covered:
1. IVD Market Overview
2. IVD Global Market Overview
4. Molecular Diagnostics
5. Clinical Chemistry
6. Diabetes and Glucose Testing
7. Immunochemistry Markets
12. Blood Banking and Screening
13. Histology and Cytology Tests
14. Data Management and Connectivity
15. Company Profiles
For more information visit http://www.researchandmarkets.com/research/8v2p9l/ivd_in_vitro